The Truth About GLP-1 Medicines in the UK (October 2026)

01 · The short version

So what is the actual truth about GLP-1?

The truth about GLP-1 medicines is that they are genuine, licensed treatments that help many adults eat less and feel fuller, and that they only work as part of a wider plan. They do not melt weight away without effort, and they are not suitable for everyone. Anyone selling them as a cosmetic shortcut, or offering to supply without a consultation or prescription, is giving you a misleading picture.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

If you want the same topic through a different lens, our guides on the wider weight loss drug picture and what to know before starting cover the practical side.

02 · Your decision

Is a GLP-1 medicine relevant to you?

A GLP-1 medicine is relevant if you are an adult living with overweight or obesity, you have already tried diet and activity changes, and you are prepared for a long-term, supervised treatment. In the UK, Mounjaro is licensed for weight management in adults and for type 2 diabetes.¹ Eligibility is judged by a prescriber on your health history, not on a quiz score, and thresholds such as a BMI of 27, 30, 35 or 40 matter in different contexts.

It is probably not the right route if you are looking for a short-term change before an event, if you have a history that a prescriber advises against, or if you are hoping the injection will replace changes to eating and activity. You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Honest suitability screening is part of the service, and unsuitable orders with us are refunded automatically.

03 · What next

What to do next

If this reads like you, the practical next step is a free online consultation, reviewed by a GPhC-registered prescriber, with no obligation. You can see current doses and costs on the Mounjaro pen page: a new customer's first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. Prefer to compare options first? Our weight loss clinic overview sets out the treatments we supply, and all six Mounjaro doses are in stock.

If you would rather ask your GP first, that is a sensible route too. NHS access is being phased in over several years.

04 · How GLP-1 works

How GLP-1 medicines actually work

GLP-1 medicines work by copying a hormone your gut already makes after eating. That hormone tells your brain you are getting full, tells your stomach to empty more slowly, and helps your body respond to insulin.

Tirzepatide, the active ingredient in Mounjaro, goes a step further. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ That is a statement about mechanism, not a claim that one person will always do better on one product. Which medicine suits you is a prescriber's judgement, based on your health, your goals and how you tolerate treatment.

What it does not do

These medicines do not burn fat directly, they do not change your metabolism overnight, and they do not remove the need to eat well. What they change is how hungry you feel and how long you feel full, which makes a reduced-calorie diet easier to follow. The online phrase "food noise" is a popular description of that quieter appetite; it is not a clinical term, and experiences differ from person to person.

Because the stomach empties more slowly, what and how you eat matters. Large, rich meals can feel uncomfortable on treatment.

Why the brand names confuse people

Ozempic, Wegovy and Mounjaro are brand names, not types of drug. Ozempic and Wegovy contain semaglutide, while Mounjaro contains tirzepatide. Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and a regulated UK pharmacy will not supply Ozempic for weight loss. Each has its own licence, strengths and dosing schedule, so advice about one cannot be assumed to apply to another. When you read a headline about "GLP-1", check which medicine and which trial it refers to before deciding what it means for you.

Our companion article, the truth about Mounjaro, focuses on that one product in more depth.

05 · What the evidence shows

What the weight-loss evidence really shows

The evidence shows that GLP-1 and GIP/GLP-1 medicines produce substantial average weight loss in trials, with wide variation between individuals. The headline numbers are real, but they are averages and they come from people who were also following a reduced-calorie diet and being more active.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

To make that concrete with a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. That is arithmetic on a trial average, not a prediction. Trial averages do not predict your own result, and some people lose less than the average while others lose more.

Averages hide the spread

An average is built from many different experiences. Some participants responded strongly, others modestly. If you are not losing weight as quickly as a headline suggests, that does not automatically mean the medicine is failing. Dose, time on treatment, eating patterns, sleep, other medicines and underlying conditions all play a part, and a prescriber review is the place to look at them together.

Comparing different trials

Be wary of lining up numbers from different trials as though they were a race. Each trial has its own participants, doses and design, so a figure from one study cannot be set against a figure from another.

Why trial duration matters

The SURMOUNT-1 results were measured over 72 weeks, which is a long period. That is worth keeping in mind when you see claims of dramatic change in a short time. Dramatic weight-loss claims in advertising or social media usually say little about how people do over a full course of treatment, and they should make you more cautious, not less.

In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴

06 · Side effects and safety

Side effects, pancreatitis and other safety concerns

GLP-1 medicines are well studied but they are not risk-free, and anyone considering them deserves a clear, calm account of the downsides. Common questions include whether these medicines can cause pancreatitis, what the usual side effects are, and what to do if something feels wrong.

Read the patient information leaflet for the specific medicine you are prescribed before you start, and keep it.¹³

Digestive effects are the usual conversation

Because these medicines work through the gut, digestive symptoms are a common topic in consultations. The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Many people find that symptoms are most noticeable when a dose changes, which is one reason doses are stepped up gradually and reviewed along the way.

Contraception

The medicine can reduce absorption of oral contraceptives because stomach emptying slows. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you use oral contraception, discuss this with your prescriber before you start and follow the guidance in the leaflet and from the MHRA.⁷

Other medicines, including diabetes treatments

If you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. That is a conversation to have with your prescriber, not a reason to adjust anything yourself.

Reporting problems

If you notice a new symptom, tell your prescriber. You can also report suspected side effects yourself through the MHRA Yellow Card scheme, which helps regulators monitor medicines.¹⁹ Tell your prescriber about any new or lasting symptom, even if it is not a listed side effect.

Counterfeits are a safety issue

Fake or unregulated weight-loss injections are a genuine risk. The MHRA publishes counterfeit medicine alerts, and you should only obtain GLP-1 medicines from a registered pharmacy after a consultation. Our registration is GPhC 9012878, and you can check any UK pharmacy on the GPhC public register.⁷ We supply Mounjaro through official LillyDirect supply, as genuine KwikPens.

07 · Myths and misinformation

GLP-1 myths worth dropping

Most GLP-1 myths come from treating a prescription medicine like a lifestyle trend.

Myth: it is a magic shot

It is not. The treatment is used alongside a reduced-calorie diet and increased physical activity, as the licensed use states.¹ Medicine makes that plan easier for many people to follow; it does not replace it.

Myth: you can "activate GLP-1 naturally" and get the same effect

Your body makes GLP-1 naturally, and eating regular, balanced meals supports healthy digestion. But there is no food, drink or supplement that reproduces the effect of a prescribed medicine. Be sceptical of anything marketed as "nature's Ozempic" or similar. Such products are typically low-cost supplements with no clinical oversight, dosing is not standardised, and they are not licensed medicines.

Myth: smoothies and special "GLP-1 diets" do the work

Food can help you feel satisfied, and there is nothing wrong with a nutritious smoothie or a balanced breakfast. But no recipe is a substitute for treatment, and no recipe boosts the medicine. If you are curious, our GLP-1 smoothie ideas page covers simple, balanced options without exaggerated claims.

Myth: it is dangerous because it is new

Newness is not the same as danger, and age is not the same as safety. What matters is the licensing evidence, the product information and professional oversight. A medicine licensed in the UK has been assessed by the regulator, and any medicine can still cause side effects in some people. That is why a prescriber reviews your history and why reviews continue during treatment.

Myth: anyone can order it with no checks

Responsible supply requires a consultation reviewed by a GPhC-registered prescriber. Mounjaro is a prescription-only medicine. Anyone offering to supply without a consultation or prescription is not operating as a regulated pharmacy, and you should avoid them.

Myth: it is vanity medicine

Obesity is a recognised medical condition, and these treatments are licensed for adults who meet the criteria. Using a licensed medicine under supervision is not a character flaw. Equally, using it for cosmetic reasons outside the licence is not something we support.

For a broader sweep of the same ground, see Mounjaro: the truth.

08 · NHS or private?

NHS or private: how people actually get GLP-1 treatment

There are two routes to a GLP-1 medicine in the UK: the NHS, where access is phased, and regulated private treatment. Neither is a loophole, and both rely on a clinician judging that the medicine is appropriate for you.

Mounjaro is available on the NHS, but access is being phased in over several years.⁴ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶

NHS access to Wegovy runs through specialist weight-management services; ask your GP.

Which route should you consider?

If you may fit the NHS criteria, speak to your GP first. It is a good, cost-free first step and it also gives you a clinician who knows your history. If you do not fit the current NHS groups, or you would rather not wait, a private route is a legitimate option as long as the provider is properly regulated.

What to check in a private provider

• The pharmacy appears on the GPhC register and the registration number matches.
• A prescriber reviews your health information before anything is supplied.
• Follow-up and dose reviews are part of the service, not an afterthought.
• Pricing is shown clearly and you know what you pay before you commit.

How we handle it

Our consultation is free, with no obligation, and the price shown is the price paid. Your answers are reviewed by a GPhC-registered prescriber, not by a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. If you want to see how the options compare, the weight loss clinic page is a good starting point.

A note on cost: private treatment is a recurring cost, and it is worth planning for the whole course rather than a single pen. Standard prices for each strength are on the product page, with a new-customer discount on first orders and a reorder discount on every future order.

09 · Costs and planning

What GLP-1 treatment costs over time

GLP-1 treatment is an ongoing cost, so the useful question is what a course looks like rather than what one pen costs. Mounjaro comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Each pen lasts four weeks, and doses are stepped up gradually, so your monthly cost changes as your strength changes.

If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A new customer's first order is £40 less, and every later order is £25 less. A first year costs £2,711.88 if you settle at 5mg, up to £3,599.88 at 15mg, again at standard prices before discounts.

If you settle at a strength between those, your monthly cost is that strength's price: £279.99 at 7.5mg, £290.99 at 10mg or £319.99 at 12.5mg, each before discounts. Across the UK pharmacies we track, Mounjaro pens ranged from £143.96 to £339.00 per month as of 10 October 2026, and the gap between providers for the same dose ranged from £27 to £41.

Why the price moved

Prices rose across the market after the manufacturer increased its list price. That is a supply-side fact, and it is the reason comparing providers on the same dose is worth the few minutes it takes. You can see our live prices, checked 10 October 2026, on the Mounjaro product page.

Paying in a way that suits you

We accept Visa and Mastercard, Klarna and pay-monthly options. There are no subscriptions and no auto-shipping; repeat orders re-check suitability each time. Delivery is free next-day tracked in temperature-controlled, discreet packaging, with same-day dispatch when you order by 3pm. Saturday delivery is £14.99.

Budget for the long term

The honest planning point is that treatment may continue for a long time, and stopping has consequences. If the monthly cost would be a stretch, say so in your consultation; a prescriber can talk through realistic options with you. Our guide what to know about GLP-1 goes through the questions worth asking before you start.

10 · Stopping and maintenance

What happens when you stop GLP-1 treatment

Stopping a GLP-1 medicine is not a clean break, because the medicine stays in your system for a while and your appetite then changes again. Planning for that is part of the truth that marketing tends to skip.

On the clearance side: tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ During that period the effect fades gradually rather than stopping on a specific day.

Maintenance is a plan, not an afterthought

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ If you are thinking about coming off treatment, speak to your prescriber first so you can agree how to keep the habits that supported your progress.

Why people stop

Common reasons include cost, side effects, reaching a goal, pregnancy planning, or simply wanting a break. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. All are reasonable, and none needs to be hidden from your prescriber. If side effects are the issue, say so, because dose changes or other support may help before you decide to stop.

Do not stretch or improvise

Do not try to extend pens, skip doses to save money or change the schedule on your own. If cost is the problem, tell your prescriber.

Keep your pens safely while you are on treatment

Unopened pens should be stored in the fridge at 2–8°C until first use and keep until the printed expiry date. Once in use, a pen can be kept out of the fridge for up to 30 days (not above 30°C), as the UK product information states.¹ Follow the instructions that come with your pen for how to inject, and dispose of needles in the sharps bin included with every order.

Support while you are on it

Ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team are part of our aftercare, alongside side-effect support. Our free companion app, GLPTrackr, helps you keep a record of your journey on iOS or Android. Some readers also find books or podcasts a useful way to stay informed; see our pick of GLP-1 books and the GLP-1 podcast guide.

11 · Eating well on treatment

Eating and lifestyle on a GLP-1 medicine

On a GLP-1 medicine the aim is a reduced-calorie diet you can actually keep up, with more physical activity, and the medicine is there to make that easier. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

People often ask what to eat on a GLP-1 diet, what not to eat, and for breakfast ideas. There is no single official GLP-1 diet.

Practical principles

• Build meals around protein, vegetables, whole grains and fibre-rich foods you enjoy, so you feel satisfied on less food.
• Eat when you are hungry, and notice when you are comfortably full, since appetite signals change on treatment.
• Be cautious with very rich, greasy or large meals if you notice they sit uncomfortably, because stomach emptying is slower.
• Stay well hydrated through the day.
• Keep physical activity going in a form you can sustain, including walking.

Foods to approach with caution

Rather than a banned list, think about foods that make you feel unwell or that deliver a lot of calories for little fullness. Highly processed snacks, sugary drinks and large portions of fried food are common examples. If a food regularly makes you feel poorly, that is useful information to share at your next review.

Breakfast ideas

Simple, balanced breakfasts work well: yoghurt with fruit and seeds, eggs with wholegrain toast, porridge with nuts, or a smoothie built on whole ingredients.

If weight loss stalls

If you are not losing weight, review the basics with your prescriber: dose and time on treatment, eating patterns, activity, sleep, stress and any other medicines. Trial averages do not predict your own result, and progress is rarely a straight line. Do not change your dose on your own.

When to ask for help

If you struggle to eat enough, feel persistently unwell, or find food a source of anxiety, tell your prescriber. Support is part of the service, and you do not have to manage this on your own.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹